Literature DB >> 3900406

Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.

M Simonet, P Berche, D Mazigh, M Veron.   

Abstract

Specific immunity against Yersinia was induced by plasmid-encoded antigens not associated with virulence. Mice were immunised with viable bacteria from a virulence-plasmid-cured strain of Y. pseudotuberculosis. This antigenic stimulation generated specific protection against virulence-plasmid-harbouring strains of Y. pseudotuberculosis and Y. pestis, demonstrating that protection can be generated by organisms lacking plasmid-encoded virulence antigens.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3900406     DOI： 10.1099/00222615-20-2-225

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN： 0022-2615            Impact factor:   2.472


  14 in total

1.  A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; Jr-Shiuan Lin; Stephen T Smiley; James B Bliska
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

2.  Oral administration of a recombinant attenuated Yersinia pseudotuberculosis strain elicits protective immunity against plague.

Authors:  Wei Sun; Shilpa Sanapala; Hannah Rahav; Roy Curtiss
Journal:  Vaccine       Date:  2015-10-26       Impact factor: 3.641

3.  YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.

Authors:  Yue Zhang; James B Bliska
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

4.  In vitro expression of a 22-kilodalton Yersinia pestis polypeptide immunologically related to the 25-kilodalton plasmid-encoded protein of the three pathogenic Yersinia species.

Authors:  M A Chalvignac; E Carniel; C Tram; A Joseph-Francois; H H Mollaret
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Authors:  Lauriane E Quenee; Claire A Cornelius; Nancy A Ciletti; Derek Elli; Olaf Schneewind
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

6.  Role of antibodies in the opsonization of Yersinia spp.

Authors:  R Tertti; E Eerola; K Granfors; R Lahesmaa-Rantala; K Pekkola-Heino; A Toivanen
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 7.  Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation.

Authors:  Tessa Bergsbaken; Brad T Cookson
Journal:  J Leukoc Biol       Date:  2009-09-04       Impact factor: 4.962

8.  Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants.

Authors:  F Bowe; P O'Gaora; D Maskell; M Cafferkey; G Dougan
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

9.  Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

Authors:  Thierry Blisnick; Patrick Ave; Michel Huerre; Elisabeth Carniel; Christian E Demeure
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

10.  Serum opsonic capacity against Yersinia enterocolitica O:3 in yersiniosis patients with or without reactive arthritis.

Authors:  R Tertti; K Granfors; R Lahesmaa-Rantala; A Toivanen
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.